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Photocrosslinkable polysaccharide hydrogel
composites based on dextran or pullulan–amylose
blends with cytokines for a human co-culture
model of human osteoblasts and endothelial cells†
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Although a large body of research has been devoted to biomaterial development for bone tissue
engineering and related medical disciplines in the last few years, novel and optimized materials especially
for bone fractures of critical sizes demand continued development. In this respect, polysaccharide-based
hydrogels demonstrate beneficial properties and fulfill the main requirements for a bone tissue scaffold as
they are hydrophilic, biocompatible, and biodegradable. The aim of the present study was the development
of a natural polysaccharide-based scaffold material that can integrate with the host tissue and support
bone regeneration. For this purpose, we prepared and investigated two polymer hydrogel composites of
photocrosslinkable derivatives of either pure dextran or a mixture of amylose and pullulan with varying
composition. In order to increase their biological activity the swollen hydrogel matrices were compounded
with stromal derived growth factor (SDF-1) and bone morphogenic protein (BMP-2). As skeletal
development is known to depend on angiogenesis, these hydrogel systems were subjected to mono- and
co-culture models of human primary osteoblasts (hOBs) with human endothelial cells (HUVEC – as precur-
sors for blood vessel development). The effect of cytokines on hydrogel-dependent cell behavior was
analyzed in the presence and absence of the growth factors SDF-1 and BMP-2. Both the employed cell
types grew on all cytokine-modified hydrogel composites, which was assessed by optical microscopy and
proliferation assays. Migration assays indicated enhanced HUVEC migration under the influence of SDF-1
and real-time PCR demonstrated an enhanced expression of cell-specific markers for growth factor-
modified hydrogels, thus demonstrating their functional bioactivity. Our results demonstrate the
fundamental potential of such multi-component polysaccharide hydrogel composites as biomaterials for
bone regeneration.
1. Introduction
Cell-based tissue engineering and regenerative medicine are
established using mostly primary cells combined with artificial
biomaterials and optionally with biological factors to improve or
replace biological functions. Due to their critical medical and
economic relevance for society these fields have been the focus of
intense research in the last few decades. Best results have been
achieved by replacing or repairing parts of or whole tissues in the
area of bone cartilage,1 skin,2 heart muscles,3 and vascular
diseases.4 Demand for the development of tailored biomaterials
suitable for regenerative medicine is high, as the target tissues
involved require stringent conditions concerning mechanical and
chemical characteristics. Often, a tailored degradation potential5
and a specific grade of porosity is implemented in the biomaterials
to allow the infiltration of growing cells into the scaffold and
formation of new tissue, eventually replacing the artificial support
material. Furthermore, materials used in medical applications
must be biocompatible, meaning ‘‘the ability of a material to
locally trigger and guide non-fibrotic wound healing, recon-
struction and tissue integration’’.6
Hydrogels are soft materials composed of water-swollen net-
works (commonly based on cross-linked hydrophilic polymers),
and have been employed in medical applications for years, such
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as wound dressing,7,8 contact lenses9–11 and drug delivery.12 Over
the last few years, this material class has gained increasing
attention for two-dimensional surface coatings as well as three-
dimensional scaffolds for tissue engineering and regenerative
medicine, since the appropriately selected base components
can fulfill all requirements needed for biomaterials in such
applications.13 Depending on the material employed they are
biocompatible, can be biodegradable, allow the diffusion of water
and dissolved species (like nutrients and oxygen) through the
hydrogel matrix, and promote cell growth of various cell types by
closely mimicking the extracellular matrix (ECM). Importantly,
their mechanical strength and stability can be finely tuned
through different modifications14 to meet the requirements for
use in tissue engineering applications. Moreover, the introduc-
tion of special functional groups in the hydrogel matrix enables
specific binding and controlled release of proteins such as growth
factors and cytokines.15
Cell-compatible hydrogels have been synthesized from a wide
range of different materials including synthetic polymers such as
polyethylene glycol (PEG) and polyacrylamide. Many natural
polymers ranging from polysaccharides including alginate and
hyaluronic acid to proteins such as fibrinogen, albumin and
collagen among others have also been investigated.13 Covalent
crosslinking of the hydrogel matrix is crucial to ensure the
structure and stability of the film or scaffold to provide sufficient
support for growing and proliferating cells, which is specifically
important for implant coatings. To further provide mechanical
integrity by the solid support, covalent attachment of the hydrogel
layers is desired. Therefore, a variety of crosslinking strategies
have been developed. Examples for chemical crosslinking include
the use of carbodiimides or glutaraldehyde as crosslinking agents,
or exposure to radiant energy to initiate the crosslinking reaction,
e.g. by light induced photocrosslinking.16–18
One particularly promising area for hydrogels as scaffold
materials is the field of bone tissue engineering for skeletal tissue
repair,19 e.g. in fractures of critical sizes that do not heal under
normal physiological circumstances. A central challenge in bone
scaffolds for regenerative medicine is angiogenesis, the formation
of new blood vessels. Many biological bone implants are rejected
by the body due to insufficient connection to the surrounding
tissue, and hence a lack of nutrients and oxygen.20 Several hydrogel
materials support cell attachment and proliferation of a wide
range of different cell types including endothelial cells, which are
physiological relevant for neovascularisation and angiogenesis.
Our approach aimed to establish the basis for a three-
dimensional scaffold for pre-vascularized bone tissue made of
photocrosslinked polysaccharide hydrogels and employing pri-
mary osteoblasts and endothelial cells. Previous work showed
that these cell types mutually influence each other positively and
enhance cell specific characteristics.21–23 As relevant polysac-
charides, dextran and pullulan24,25 support cell growth and
proliferation of endothelial cells, osteoblast and other cell
types.26 Both polymers are promising candidates to be employed
in hydrogel matrix systems for tissue engineering and regenerative
medicine. Pullulan demonstrates good water solubility,27 making
processing and modification steps under mild aqueous conditions
possible. Furthermore, its hydrogels exhibit excellent mechanical
stability with high water retention capacity.28 Similarly, dextran
is a water soluble, nontoxic and biodegradable polysaccharide,
which is able to form hydrogels with various other components.29
Both polysaccharides are generally considered biocompatible,30
yet not much research has been reported concerning their
suitability as scaffold materials for bone tissue engineering in
a three-dimensional co-culture model. In our previous study,
we analyzed a dextran hydrogel system with BMP-2 for its
biocompatibility and influence on osteoblasts and HUVECs24
for its potential use as a biomaterial for cell-based tissue
engineering.
Based on this background, we investigate here a new photo-
crosslinked pullulan–amylose blend hydrogel in reference to the
previously examined dextran system and further expand this
study with SDF-1 as a new cytokine and by employing additional
methods, like migration essays, monitoring the marker expression
and influence on angiogenesis, etc.
2. Experimental details
2.1 Polymer synthesis and hydrogel preparation
Synthesis of 4-(2,3-epoxypropyloxy) benzophenone (EBP). The
synthesis of EBP was performed according to the literature.31,32
Typically, 4 g (20.2 mmol) of 4-hydroxybenzophenone (Alfa Aesar,
98% purity), 13.3 g (143.4 mmol) of epichlorohydrin (Alfa Aeser,
99% purity) and 4.50 g (32.3 mmol) of anhydrous potassium
carbonate powder were dissolved in butanone (100 ml) and
0.8 ml of polyethylene glycol 400 were added. The solution was
stirred and heated for 20 hours at 80 1C and then refluxed for
4 hours at 120 1C. After filtration, the inorganic residue was
washed with butanone until the solution became colourless. The
combined organic phase was concentrated by rotary evaporation
and the residue was extracted with a chloroform/water mixture.
Subsequently, the two phases were separated and the chloroform
phase was dried over anhydrous calcium chloride. After drying,
the yield of the crude product was 485%. The material was
recrystallized from ethanol prior to further use.
1H-NMR (CDCl3, 400 MHz): d (ppm) 7.90–7.25, 6.98 (9H,
protons of aromatic ring); 4.33 (1H, H10), 4.03 (1H, H1), 3.80
(1H, H2), 3.40 (1H, H30), 2.80 (1H, H3) (protons of epoxy group).
EBP-coupling to the polysaccharides. To attach the benzo-
phenone unit via an ether linkage to the polysaccharide back-
bone, typically 5 g (equivalent to 0.03 mol AGU (anhydroglucose
units)) of dextran, amylose or pullulan were dissolved in approxi-
mately 350 ml dry DMSO. 1.35 g (0.056 mol) of sodium hydride
(Sigma Aldrich) were added slowly. After stirring for 30 min, 1.7 g
(0.007 mol) of EBP were added and the mixture was stirred at
room temperature overnight. The reaction was terminated by
careful addition of 100 ml of distilled water and the product was
precipitated in approximately 1 L of ice-cold acetone. The yields
of the ether products were 70% for EBP-dextran (EBP-D), 60% for
EBP-amylose (EBP-A) and 90% for EBP-pullulan (EBP-P).
EBP-D: 1H-NMR (D2O, 400 MHz): d (ppm) 7.90–6.48 (9H, arom.
BP), 5.00, (1H, H1), 4.00 (1H, H6), 3.93 (1H, H5), 3.75 (2H, H60, H3),
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3.55 (2H, H2, H4). DS-EBP (degree of substitution of benzophe-
none groups): 0.03.
EBP-A: 1H-NMR (DMSO-d6, 400 MHz): d (ppm) 7.75–7.10 (9H,
arom. BP), 5.09, (1H, CH1), 4.17 (1H, H6), 3.66 (1H, H5), 3.34 (2H,
H60, H3), 3.24 (2H, H2, H4). DS-EBP: 0.01.
EBP-P: 1H-NMR (D2O, 400 MHz): d (ppm) 7.75–7.11 (9H, arom.
BP), 5.01, 4.66 (1H, H1), 3.70 (1H, H60), 3.62 (1H, H5), 3.52 (2H,
H6, H3), 3.34 (2H, H2, H4). DS-EBP: 0.05.
Carboxymethylation of the EBP-polysaccharides. For the sub-
sequent carboxymethylation, typically 5 g of the benzophenone-
modified polysaccharide were dissolved in 150 ml distilled water
followed by the addition of 10 g (0.1 mol) of sodium chloroacetate
(Acros Organics, 98% purity). To initiate the reaction, 50 ml of
8 M aqueous sodium hydroxide solution were added and the
reaction was carried out for 1 hour (only for pullulan 4 days) at
62 1C. After cooling down for 10 minutes, the carboxymethylated
polymers were precipitated into methanol and washed with a
methanol–water-mixture (9 : 1). The yields were 60% for the
dextran derivative EBP-CMD, 65% amylose derivative EBP-CMA
and 60% pullulan derivative EBP-CMP.
EBP-CMD: 1H-NMR (D2O, 400 MHz): d (ppm) 7.90–7.17 (9H,
arom. BP), 5.22, 5.00, (1H, H1), 4.24, 4.19 (2H, MeCMH), 3.97 (1H,
H6), 3.89 (1H, H5), 3.70 (2H, H60, H3), 3.53 (2H, H2, H4). DS-CM
(degree of substitution of carboxymethyl groups): 0.2.
EBP-CMA: 1H-NMR (DMSO-d6, 400 MHz): d (ppm) 7.89–7.24
(9H, arom. BP), 5.63, 5.34, (1H, CH1), 4.36–4.12 (2H, MeCMH),
3.99 (1H, H6), 3.92 (1H, H5), 3.68 (2H, H60, H3), 3.59 (2H, H2,
H4). DS: 0.17–0.22.
EBP-CMP: 1H-NMR (DMSO-d6, 400 MHz): d (ppm) 7.90–7.18 (9H,
arom. BP), 5.64, 4.90 (1H, H1), 4.18 (2H, MeCMH), 4.07 (1H, H60),
3.88 (1H, H5), 3.77 (2H, H6, H3), 3.56 (2H, H2, H4). DS: 0.21–0.29.
GPC analysis, all in phosphate buffer: (more details provided
in the ESI†)
Dextran: Mn = 7.44  103 g mol1, Mw = 4.51  104 g mol1
EBP-CMD: Mn = 3.23  103 g mol1, Mw = 1.06  104 g mol1
Pullulan: Mn = 5.10  104 g mol1, Mw = 1.98  105 g mol1
EBP-CMP: Mn = 7.00  103 g mol1, Mw = 3.95  104 g mol1
Amylose: Mn = 1.38  105 g mol1, Mw = 3.30  105 g mol1
(the polymer was passed through a 0.45 mm filter prior to
recording GPC data to remove insoluble components)
EBP-CMA: Mn = 7.11  103 g mol1, Mw = 8.47  104 g mol1
Synthesis of the adhesion polymer P(85NIPAAm-5MAA-
10BPAAm). The adhesion polymer, here abbreviated P(85NIPAAm-
5MAA-10BPAAm), was obtained by free radical copolymerization of
85 mol% N-isopropylacrylamide (NIPAAm, recrystallized from
n-hexane), 5 mol% methacrylic acid (MAA) (destabilised and purified
over an Al2O3 column) and 10 mol% N-(4-benzoylphenyl)acrylamide
(BPAAm) following the procedure described by Beines et al.33 The
molar mass of Mn = 5.0  104 g mol1 and Mw = 1.4  105 g mol1
was measured by GPC (Agilent 1260 infinity) on a GRAM LinM
column in dimethylacetamide and 0.1% LiBr at 60 1C (injection
volume/flow rate, 20 ml/1 ml min1). 1H-NMR (CDCl3, 400 MHz):
d = 1.27 (s, 6 H, 2 CH3), 1.48–2.40 (backbone), 3.80–4.10 (br. s, 1 H,
CH(CH3)2), 7.36–7.90 (BPAAm). BPAAm was synthesized from
4-aminobenzophenone and acryloyl chloride with triethylamine
as base according to Jia et al.34
Preparation of the hydrogel layers in 24-well plates. Polystyrene
24-well plates were rinsed several times with ethanol, dried
and coated with the P(85NIPAM-5MAA-10BPAAm) adhesion
polymer. Briefly, 60 ml of a 0.25% (w/w) polymer solution in
70 : 30 (v/v) ethanol : water were applied to each well of a 24 well
TCPS plate. The solvent was evaporated at room temperature while
shaking gently to ensure even film formation. After drying, the
samples were irradiated for one hour at 365 nm (17 J cm2) under
nitrogen to induce crosslinking (UVP CL-1000 Ultraviolet Cross-
linker). Subsequently, aqueous solutions of EBP-CMA, EBP-CMP,
EBP-CMA and the respective mixtures for the composites were
prepared. An aqueous solution of gelatin was added dropwise to
the polymer solution while stirring followed by the addition of
benzophenone-modified silica particles35 to a final concentration
of 10 w% with respect to the polymer. The mechanical properties
including swelling behaviour, critical temperature and SPR/OWS
experiments have been described for an analogous hydrogel
system by van den Brom et al.35 300 ml of the respective final
mixtures were added into each well and dried at 37 1C for 18 h.
After drying, the samples were irradiated for one hour at 254 nm
(10.4 J cm2) under nitrogen. To investigate the porous super-
structure of the hydrogels cryo-SEM measurements were carried
out. Therefore, a part of dried bulk hydrogels was crosslinked,
swollen in buffer, and frozen in liquid nitrogen. After the water
was sublimed the hydrogels were coated with platinum and
observed using a cryo-SEM under high vacuum (Fig. S2, ESI†).
The measurements show a macroporous structure in the micro-
meter range which is consistent with the literature for various
dextran based hydrogel systems.36 These results clearly indicate
that macropores exist in the hydrogel matrix. One has to keep in
mind that the macropores are not expected to represent rigid
pores in the swollen state, but rather resemble a flexible network.
Binding and release of cytokines. Growth factors (300 ng per
well) were entrapped in the hydrogels in presence and absence of
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC
HCl, Applichem, Darmstadt, Germany) and N-hydroxysuccinimide
(NHS, Sigma Aldrich) according to the following protocol. First, the
hydrogels were washed three times with 1 phosphate buffered
saline PBS (Dulbecco, Invitrogen). Subsequently, they were incu-
bated in PBS for 30 minutes at room temperature to allow swelling
and equilibration of the gels. A 0.4 M aqueous solution of EDC HCl
was mixed 1 : 1 (v/v) with a 0.1 M aqueous solution of NHS, added
directly to the hydrogels (500 ml/24 wells) and incubated for 10 min
at room temperature before the respective growth factors were
added BMP-2 (stock solution: 10 mg ml1 in PBS) and SDF-1 (stock
solution: 100 mg ml1 in PBS), (Miltenyi, Bergisch Gladbach,
Germany). After an incubation period of 1 hour and a short rinsing
step with PBS, the modified gels were used in further experiments.
The release of the entrapped growth factors was measured
employing specific ELISA-tests (abcam, Cambridge, Great Britain)
after 1, 2, 3, 4, 8, 24 and 30 hours. For a clearer presentation of
the release data, the measured concentrations of the growth
factors after 8, 24 and 30 hours were divided by the time intervals
between release measurements (difference in hours and converted
to release/hour). All experiments were performed in triplicate and
repeated three times.
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In vitro cytotoxicity assessment of hydrogels. The in vitro
cytotoxicity was analysed employing the MTT ([3-(4,5-dimethyl-
thiazol-2-yl)-(2,5-diphenyltetrazolium bromide)]) assay analogous
to ISO 10993-5. Mouse L929 cells (20 000 cells per well) were
seeded in a 96 well tissue culture polystyrene (TCPS) plate for
24 hours before they were exposed to 100 ml fluid extracts from
the hydrogels after incubation for 24 hours. One group of three
dextran/amylose (50 : 50) and pullulan–amylose (50 : 50) hydro-
gels, respectively, was washed with PBS three times before culture
media were added and incubated for 24 hours. 100 ml of this
extract were added to L929 cells in the 96 well plate. After an
incubation time of 24 hours, the MTT assay was performed
according to ISO 10993-5. The colorimetric readout was per-
formed at a wavelength of 570 nm (reference wavelength
650 nm). Another group was incubated with cell culture media
without PBS washing steps and treated as the previous group.
Polyurethane membranes stabilized with organic zinc derivatives
ZDEC (zinc diethyl dithiocarbamate) and ZDBC (zinc dibutyl
dithiocarbamate) (Food and Drug Safety Center, Hatano Research
Institute, Ochiai 729-5, Hadanoshi, Kanagawa 257, Japan) were
used as positive controls. These controls induce a reproducible
cytotoxic reaction.
2.2 Cell experiments
Primary human osteoblasts (hOBs). Osteoblast cultures were
prepared from cancellous bone fragments taken from patients
undergoing orthopedic and trauma surgery. Informed consent
was obtained from all patients, and the local ethical committee
approved the investigations [No: RLP 837.046.03(3708)]. Isolation
was performed as described previously.37 In short, the fragments
were digested with collagenase type IV (Sigma-Aldrich), washed with
PBS to remove blood and fat residues and the clean bone fragments
were placed in 6-well plates (Becton-Dickinson, Heidelberg) and
cultured in DMEM/F12 (Biochrom, Germany) supplemented with
10% heat inactivated fetal calf serum (PAA Lab, Austria), 100 U ml1
penicillin and 100 mg ml1 streptomycin sulfate at 37 1C, 5% CO2.
The specific phenotype was assessed by the expression of
alkaline phosphatase visualized by using 5-bromo-4-chloro-3-
indolyl-phosphate/nitro-blue-tetrazolium as a substrate (Sigma-
Aldrich) and mineralization of the extracellular matrix using
Alizarin Red-S (Sigma-Aldrich) (ESI,† Fig. S1) after cultivation in
differentiation media (DMEM/F12, 10%FCS, 100 U ml1 penicil-
lin and 100 mg ml1 streptomycin sulfate containing 200 mg ml1
ascorbate, 108 M dexamethasone and 50 mg ml1 b-glycerophos-
phate) for four weeks. For cell culture experiments, undifferentiated
osteoblasts in passages 2–4 were used.
Human umbilical vein endothelial cells (HUVECs). HUVECs
were purchased from PromoCell GmbH (Heidelberg, Germany)
and cultured in EBM-2 (endothelial cell growth medium, Lonza,
Walkersville, USA) supplemented with the provided kit, as well as
with 100 U ml1 penicillin, and 100 mg ml1 streptomycin sulfate,
in a humidified atmosphere (5% CO2, 37 1C). Media were changed
twice a week. Cells up to passage eight were used for experiments.
Lentiviral vector particle production and transduction of
fibroblasts. The eGFP or cherry protein encoding lentiviral vector
pHR’-SEW was used to prepare vector supernatants by transfection
of 293T cells as previously described.38 For gene transfer, 15 000
human osteoblasts (hOBs) or HUVECs were seeded into 24-well
tissue culture plates (Greiner, Frickenhausen, Germany) in
500 ml media supplemented with 5 mg ml1 protamine sulfate.
Two rounds of transduction on day 1 and 3 were performed at a
cumulative multiplicity of infection (MOI) of B100 to achieve
498% gene marking. Transduction efficiency was confirmed by
fluorescence microscopy (Wilovert AFL30, Hundt GmbH, Wetzlar,
Germany) and flow cytometry FACSCalibur (BD Biosciences,
San Jose, USA) using the CellQuestPro Software (BD Biosciences,
San Jose, USA).
Mono- and co-cultures on polysaccharide hydrogels. Before
cell seeding, the hydrogel films in the 24 well plates were washed
three times with sterile PBS (Dulbecco, Invitrogen) to remove
potential chemical residues that remained from hydrogel
synthesis. After the last washing step, the hydrogels were
incubated for at least 30 minutes with PBS at room temperature
to allow swelling equilibration. The PBS was removed and the
cells were seeded in monoculture (100 000 cells) or co-culture from
HUVECs and hOBs (50 000 cells each). The incubated hydrogels
were cultured for four weeks with media change twice a week.
Microscopy analyses were performed every two days and the photos
of the hydrogels were taken for data collection using the EVOS Cell
Imaging System (Life Technologies, Darmstadt, Germany).
Proliferation assays. Cell viability and proliferation on the
hydrogel films were measured using the semi-quantitative colori-
metric alamarBlue assay (Invitrogen, Karlsruhe, Germany). Cells
were seeded on the hydrogels as described above and after
24 hours of incubation, the medium was removed and replaced
by a culture medium solution containing 10% alamarBlue. The
hydrogels with cells were further incubated for 4 h at 37 1C.
Aliquots of 100 ml were transferred into the wells of 96 well plates
and the fluorescence was measured using a fluorescence reader
(Glomax, Promega, Mannheim, Germany) at 590 nm (emission
wavelength 580–610, excitation wavelength 540–570 nm). The
assay was performed once every 24 hours over a time period of
five days. The cell proliferation correlates with the fluorescence
intensity. As a negative control, alamarBlue was added to the
hydrogels with cell growth medium without cells.
Migration assays. For migration assays, cell culture inserts
with a pore size of 8 mm for a 24 well format were used (BD
Biosciences). 100 000 lentiviral transduced cells were seeded in
the culture insert placed in a 24 well plate modified with hydrogel
films. Migration of cells through the insert pores was measured
using a fluorescence reader (Glomax, emission wavelength 490 nm,
excitation wavelength 510–570 nm) after two, three and six days
and correlated to a standard curve and compared to a negative
control (hydrogels without growth factor modification).
Gene expression analyses by real-time PCR. The total RNA
was extracted using TRIzol–chloroform (Invitrogen, Karlsruhe,
Germany) and purified employing an RNeasy Micro Kit (Qiagen
GmbH, Hilden, Germany) according to the manufacturer’s
instructions. Quantitative real-time PCR was performed to
evaluate the stability of the hOB and HUVEC phenotypes by
analyzing the expression of various differentiation markers using
the 7300 ABI sequence detection system (Applied Biosystems).
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Validated QuantiTech Primer. Assay Kits were used for the following
genes: ALP (QT00012957), CD31 (QT00081172), osteopontin
(QT01008798), von-Willebrand-factor (QT00051975), Cbfa1/
Runx2 (QT00020517), and 18S RNA housekeeping gene as the
control (QT00199367). Real-time PCR reactions were carried out
using 100 ng cDNA samples, 1XQuantiTech primers, and
1XQuantiTech SYBR-Green PCR master mix in a total volume
of 20 ml using the suggested thermal profiles. The data were
analyzed using SDS 2.1 software (Applied Biosystems) and quanti-
fied using the 2 dCt method. Reverse transcription was performed
using 2 mg of RNA from each sample, random primers (Promega)
and superscript III reverse transcriptase (Invitrogen).
Statistical analyses. All experiments and measurements were
performed at least in triplicate and represented as bar graphs
with medians and standard deviations (cytotoxicity, cytokine
release). For statistical analysis (proliferation, migration, PCR),
the IBM SPSS Statistics software version 23 was used. The data
distribution was defined by medians  quartiles. The measure-
ment values were normalized to the median of the control group
(control median) and presented as %-values related to the control
group in bars or box-plots.
For multiple comparisons, the paired non-parametric Wilcoxon-
test was performed, as the Kolmogorov–Smirnov test did not
demonstrate a normal data distribution. Differences were
considered to be statistically significant for p o 0.05.
3. Results and discussion
3.1 Hydrogel systems
In the present study, we investigated the cellular response of
endothelial cells and osteoblast cells towards two-dimensional
hydrogel systems based on photocrosslinkable polysaccharide
composites. The hydrogel components comprised carboxymethy-
lated polysaccharides derived from dextran (Dex) or from pull-
ulan (Pull) blended with amylose (Amy). Amylose was added to
the pullulan gel matrix as an enzyme-digestible component39 to
provide increased gel porosity and nutrition for cells during
attachment, growth and proliferation phases. Fast degradation
(within hours) of the hydrogel films under cell culture conditions
was observed for pure photocrosslinked amylose systems, corro-
borating their digestible nature. Simultaneously, enrichment
with gelatin was employed to provide nutrition and enhance
cell–hydrogel interaction.24 In the pullulan–amylose composites,
comparison between gelatin-enriched with gelatin-free hydrogels
allowed to distinguish the effect of amylose from the effect of
gelatin on the cellular response (see, for example, Fig. 4).
To improve the mechanical stability in the hydrogel layers
benzophenone-functionalized silica nanoparticles (SiO2NP) were
incorporated in the gel matrix. Through the BP-functionalities on
the particle surface, covalent anchorage within the polymer net-
work was achieved via multiple attachment points. This ‘‘super-
crosslinking’’ effect of the functionalized nanoparticles leads to a
substantial increase in mechanical robustness with a reduced
swelling ratio (as previously investigated in detail for another
hydrogel layer system35), which is also directly observable when
handling the hydrogel films, as nanoparticle-free gels are extremely
soft and easily punctured by a pipette tip.
In order to ensure firm attachment to the substrate material
(TCPS dish) and the formation of a uniform layer of hydrogel
composites, a thin layer of an adhesion polymer was first applied
to the TCPS surface. This terpolymer consisting of NIPAAM,
BPAAm and MAA was synthesized via free radical polymerization.
It was subsequently dissolved in an ethanol/water mixture at
0.25 weight % and applied to the substrate material as a thin film.
Even spreading of the film during drying was ensured through
placement on a shaker. After evaporation of the solvent a clear
polymeric film was obtained and crosslinking with simultaneous
attachment to the substrate was induced by irradiation at 356 nm
(17 J cm2) for one hour in a nitrogen atmosphere. Subsequently,
aqueous solutions containing the composite systems dextran/
gelatin/SiO2NP or pullulan/amylose/gelatin/SiO2NP were applied
to the wells. The solvent was evaporated at 37 1C in the dark. After
removal of the solvent, attachment to the substrate as well as
crosslinking of the hydrogels was achieved through UV-exposure
at 254 nm (10.4 J cm2) for one hour under nitrogen atmosphere.
On these different hydrogel composites, mono- and co-culture
models were tested for human osteoblasts (hOBs) and endothelial
cells (HUVECs) in order to assess the suitability of these poly-
saccharide materials as growth supports in bone replacement
applications.
Hydrogels with pure amylose, although stable in water or PBS,
demonstrated a low stability and completely degraded within a
few hours after cell seeding, for which we speculate that enzy-
matic degradation might be responsible for the instability of pure
amylose hydrogels. In contrast, pure pullulan hydrogels showed a
hard cell repellent structure even after swelling. On these hydrogels,
no cell attachment and growth was detected. As these single
polysaccharide systems did not demonstrate enhanced cell sup-
port properties they were not further investigated. On the other
hand, pure dextran hydrogels showed slightly better stability with
minor cell attachment and growth as already demonstrated by
our former study.24 In order to investigate the combined properties
of amylose (fast degradation as nutrition supply) and pullulan
(providing a stable hydrogel support) several polymer blends of
both polysaccharides were prepared. The two polymers were
mixed at ratios of 25/75; 50/50; and 75/25 (w/w), respectively. As
mentioned above, all pullulan–amylose blends as well as the pure
dextran system were further modified with 10 w% gelatin and
10 w% silica particles to enhance cell growth and increase the
mechanical stability of the gels. Brom et al.35 described the
synthesis of modified silica nanoparticles, their incorporation in
poly(N-isopropylacrylamide)-based (PNIPAAm) hydrogels and
their influence on swelling behavior and stability. They demon-
strated an even distribution of nanoparticles in the gels and
showed that the NPs served as a supercrosslinking agent, providing
a more rigid structure. In our former study, we tested various
concentrations of silica particles in dextran gels24 (data not
shown) and experimentally found that a concentration of 10%
silica nanoparticles demonstrated the best ratio between stability,
swelling ratio and cell growth. These results were transferred to
the amylose–pullulan hydrogels here and the cellular analyses
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suggest that the mechanical effect of silica nanoparticles on
dextran and amylose–pullulan hydrogels is comparable to the
PNIPAAm system. A detailed assessment of the exact influence of
silica particles on these models has to be performed in a further
study (Fig. 1).
3.2 Cytotoxicity/MTT assays
Cytotoxicity assays were performed to demonstrate the biocom-
patibility and non-toxicity of polysaccharide hydrogels used in
this study analogous to ISO10993-5. L929 mouse fibroblasts were
incubated in hydrogel extracts containing dextran or three dif-
ferent variations of pullulan and amylose mixtures (25/75; 50/50;
and 75/25 w/w%). No cytotoxic effects were observed, as is evident
from the high cell viability ranging from 93–126% (Fig. 2). A cell
viability of 100% corresponds to cells growing on tissue culture
treated polystyrene substrates. Cell viabilities 470% indicate
no cytotoxic effects, whereas cell viability between 0 and 40%
represents high cytotoxicity, which is represented by the positive
controls (ZDEC and ZDBC as polyurethane matrices stabilized
with organic zinc, see Experimental details).
These results demonstrate high cell compatibility of the
polysaccharide hydrogels used. Only little data are available
concerning the biocompatibility and cytotoxicity of the specific
carboxymethylated and benzophenone-modified polysaccharides
used in this study and their potential as materials for bone tissue
engineering.26,28–30,39–41 In addition, while few groups have
already demonstrated the insertion of amylose in hydrogel
preparations,42–44 no data are available on amylose as a
component in hydrogels for cell growth. Mixing of various
polysaccharides to generate blends or composites is a common
approach to combine desirable effects of the individual polysac-
charides. For example, mixtures of pullulan with other biopoly-
mers, e.g. collagen,45–47 were demonstrated to be biocompatible.
Cytotoxicity tests for the adhesion polymer based on NIPAAM,
MAA and BPAAm were performed in an independent study and
showed low cell adhesion with no cytotoxic effects.48
It is of tremendous importance to ensure transferability of the
developed methodology to different substrate materials. For
example, titanium is routinely used in bone replacement applica-
tions due to its outstanding mechanical properties. A composite
material consisting of titanium, an adhesion polymer and a
polysaccharide hydrogel modified with cells and/or cytokines
could enhance fracture healing. The prerequisite for such a
material is the demonstrated cell compatibility of the adhesion
polymer and polysaccharide hydrogel.
3.3 Growth factor release
In order to assess the effect of hydrogel-associated cytokines on
cell growth and differentiation, 300 ng per well of the growth
factors SDF-1 and BMP-2, respectively, were used for the entrapment
procedure (see Experimental details) of the various hydrogels plated
in 24 well plates. The release rate was measured in the super-
natant by a specific ELISA-test. In all tested hydrogels, the
amount of cytokines released was comparable, and therefore
the results are averaged in Fig. 3.
Cytokine concentrations in the supernatant of the hydrogels
were measured after adsorption of the growth factors in the gels
with and without addition of linker molecules (EDC & NHS).
Without linker molecules, 95% of the growth factors were
released within eight hours after binding. With EDC/NHS linking,
approximately 90% of the cytokines were released after 30 hours
(Fig. 3A). The remaining 10% were either released at concentra-
tions below the detection limit or covalently immobilized in the
hydrogel matrix. This might indicate that EDC and NHS in
combination alter the solvation characteristics of the hydrogels,
hence causing a slower release of cytokines from the gel matrix.
Fig. 1 Schematic of the hydrogel layer structure and the corresponding
polymers used in this cell culture study.
Fig. 2 Cytotoxicity assay (MTT) demonstrating cell growth compared
to the cell culture treated polystyrene (Dex: dextran-based hydrogel
composite, Pull/Amy: pullulan–amylose-based hydrogel composite, ZDEC:
zinc diethyl dithiocarbamate-releasing polyurethane, ZDBC: zinc dibutyl
dithiocarbamate-releasing polyurethane).
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However, further experiments are required to confirm this
hypothesis.
All hydrogels that were treated with cytokines in the presence
of EDC/NHS show a high initial release in the first hour (59.2 ng
SDF-1 per h and 56.4 ng BMP-2 per h), which corresponds to
approximately one fifth of the total amount of cytokines applied.
This high initial release is followed by reduced release rates of
25.9–19.5 ng SDF-1 per h and 23–16.1 ng BMP-2 per h up to
8 hours, respectively. From 8 to 30 hours, the rate declines further
to 10.5–3.5 ng SDF-1 per h and 12.8–2.9 ng BMP-2 per h; after that
no cytokines can be detected in the supernatant. The total
amount of cytokines released is 88.5% for SDF-1 and 87.9% for
BMP-2 (Fig. 3B).
BMP-2 was chosen since its role in osteogenesis is well defined49
and its functional activity can readily be assessed by determination
of the enhancement of osteoblast marker expression by real-time
PCR. BMP-2 exerts inductive properties on osteoblasts as well as on
mesenchymal stem cells (MSCs). It enhances osteoblast differen-
tiation, mineralization as well as extracellular matrix production
via at least two pathways, one mediated by SMAD molecules and
the other by p38/MAPK (mitogen activated protein kinase).49
SDF-1 on the other hand is known to induce angiogenesis by
homing CD34+-cells and MSC via CXCR4.50
After incubation of the hydrogels with the respective growth
factors in the presence of EDC/NHS we could demonstrate the
cytokine release over 30 hours. This is in line with the available
literature and was shown to be sufficient for an enhanced healing
effect.51 Both cytokines show a short half-life in blood (SDF-1
approx. 25 min;52 BMP-2 7–16 min53). One therapeutic application
of these hydrogels might be a carrier system for cytokines
potentially as a composite material in combination with a resorbable
bone replacement material. The release kinetics demonstrated
by our hydrogels with initially high concentrations and the
following lower release over 30 hours will be adequate for
chemotactic activation of stem cells and to enhance osteoblast
activation.54
3.4 Cell growth
In order to monitor the influence of the various polysaccharide
hydrogels on different cell types, the cell morphology, cell
clustering and cell–cell interaction were analyzed microscopically
over a time span of maximum four weeks. In the absence of
growth factors, cell growth was observed for osteoblasts (hOBs,
transduced with green fluorescent protein) in monocultures as
well as hOB/HUVEC co-cultures. In line with previous studies24,37
no cell growth was observed in HUVEC (transduced with cherry
red protein) monocultures. After incubation of the hydrogels with
the respective growth factors SDF-1 and BMP-2, cell growth
occurred in the co-cultures as well as in the monocultures of
both cell types, highlighting the retained function of growth
factors after entrapment and release from the hydrogel matrix.
Both monocultures grew preferentially along the buckling struc-
ture of the hydrogels, indicating a topographical influence on cell
alignment. Nevertheless, the following differences could be
detected concerning the mode and arrangement in co-cultures:
On pullulan–amylose gels with and without additional gelatin
and SiO2NPs the co-cultures formed spheroid-like structures and
began to form very small sprouts (Fig. 4, arrows). This was
observed in both types of pullulan–amylose gels with and without
additional gelatin and SiO2NPs. The spheroids were formed by
both cell types, with osteoblasts (green) being rather in the center
and endothelial cells (red) apparently surrounding the osteo-
blasts; this effect is more enhanced in the gels without silica
particles/gelatin. In contrast, the growth of co-cultures on dextran
gels was comparable to the growth of the monocultures and
followed the topographic structure of the gels (Fig. 4D, yellow,
indicating both cell types growing on the very spot). In a former
study, we could already demonstrate that cell growth on dextran
gels with SiO2NPs and gelatin particles is enhanced, as the
microscopic analyses with these gels show.24
Fig. 4 shows cell growth with mono- and co-cultures after
addition and release of both growth factors. Importantly, cell
growth in monocultures is comparable between all types of
hydrogels employed but cell growth patterns in co-cultures vary
between different hydrogel systems. In particular, on dextran-
based hydrogels the co-cultures grow in an adhesive manner
along wrinkles in the hydrogel structure. This is indicated by
the spread morphology of the cultured cells, indicating a cell
supportive base material. On the contrary, on pullulan–amylose
gels cells form spheroid-like clusters, indicating a less cell adhesive
hydrogel base. SEM analyses (see ESI,† Fig. S2) demonstrated
macropores in the dried state under SEM conditions in the dextran
hydrogels, which potentially augment cell growth along the
Fig. 3 (A) ELISA assay analysis of the cumulative release of SDF1 and
BMP2 for hydrogels treated with and without linker molecules EDC and
NHS over a period of 30 hours. (B) The total amount of cytokines (treated
with EDC/NHS) released from hydrogels over a period of 30 hours.
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topographic features of the gels and allow partial cell penetration
into the film surface. The results indicate that dextran enhances
the adhesion of the cells, whereas the amylose–pullulan mixture,
although biocompatible, does not significantly support cell
adhesion. Interestingly, in contrast to dextran gels, where we
detected major differences in cell growth on gels with and without
silica/gelatin addition,24 these differences were not seen on pullulan–
amylose gels. However, these differences imply various possible
applications for the analyzed hydrogels: although dextran hydro-
gels show improved cell growth, pullulan–amylose gels might be
advantageous as carrier systems for cytokines. This interesting
perspective will be explored in follow-up studies.
Although previous studies investigated the biocompatibility of
dextran–pullulan and amylose hydrogels,25,55 not much is known
about the cell growth characteristics of various cell types on these
hydrogels. Thebaud et al.56 analyzed endothelial cell growth on
pullulan–dextran–fucoidan hydrogels, that were crosslinked
chemically with sodium trimetaphosphate, and observed cell
adhesion after 24 hours culture. However, they did not analyze
cell growth over longer periods of time. This might explain the
differences in our results as we focused on longer culture periods,
where we only observed endothelial cell growth after addition
of growth factors. To our knowledge, no studies assessing cell
growth, especially over extended periods of time, have been
performed on amylose or amylose-containing hydrogels.
3.5 AlamarBlue assay
Cell proliferation and viability of mono- and co-cultures on the
different hydrogel substrates were quantified via the alamarBlue
assay. Pure pullulan hydrogels did no swell substantially after
incubation in PBS, whereas pure amylose hydrogels (data not
shown) as well as the dextran hydrogels without SiO2NPs or
gelatin exhibited only limited stability after swelling, and there-
fore no cells were seeded on these hydrogels. Dextran hydrogel
composites with SiO2NPs and gelatin as well as hydrogels with
different ratios of pullulan and amylose reinforced with SiO2NPs
and supplemented with gelatin demonstrated a high stability after
swelling. Therefore, hOB cells and HUVECs were seeded on these
hydrogels after entrapment of BMP-2 and SDF-1, respectively.
As already observed in the microscopic studies above, the
alamarBlue proliferation assay documented that hOBs grew well
on the tested polysaccharide hydrogel composites even in the
absence of growth factors BMP-2 and SDF-1. The growth could be
slightly enhanced by approximately 10% on hydrogel composites
Fig. 4 Optical microscopy investigation of cell growth on the different hydrogel substrate types: dextran hydrogels with gelatin and silica particles,
pullulan–amylose gels with and without gelatin and silica particles. (A) After swelling; (B) monoculture osteoblasts; (C) monoculture HUVECs; (D) co-
culture osteoblasts and HUVECs. Scale bars represent 200 mm.
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with entrapped BMP-2. However, this enhancement was shown to
be non-significant (p-value 4 0.05). Comparing the overall growth
behavior of hOBs on dextran hydrogels and pullulan–amylose
gels, proliferation of hOBs was significantly higher (p o 0.05) on
dextran gels, as indicated by the higher fluorescence intensity
after four and five days (Fig. 5).
At the same time, HUVECs did not proliferate on any of the
tested hydrogel composites without growth factors. This is in
accordance with the microscopic observations above and
previous literature reports, where the growth of HUVEC mono-
cultures in three-dimensional models could not be established.37
However, our alamarBlue assay indicated that entrapment of
SDF-1 in the hydrogel matrix substantially enhanced cell growth
on all tested polysaccharide hydrogel composites (p o 0.05).
Compared to pullulan–amylose hydrogels, the dextran hydrogels
with cytokines showed a significantly enhanced proliferation
(p o 0.05, Fig. 5). The fact that addition of SDF-1 significantly
enhances proliferation of endothelial cells on the tested hydro-
gels indicates that the growth factor retains its functional activity
after incorporation into the hydrogel composites, which has also
been demonstrated for other types of hydrogels.15,57,58 This
observation indicates various potential options for medical
applications for these hydrogel composites and controlled
cytokine release.
3.6 Migration assays
In order to determine the biologic function of entrapped SDF-1,
particularly its chemotactic influence on endothelial cells,
migration assays with cell culture inserts containing pores of
8 mm was performed (for the experimental setup, see Fig. 6A).
The migration of HUVECs from the chamber to the modified
hydrogel was observed after addition of SDF-1 in all the gels
used. This is in strong contrast to HUVECs cultured on hydrogel
composites without SDF-1, where no migration activity of HUVECs
was detected.
A standard curve was established correlating the fluorescence
intensity with the cell number. Fig. 6 shows the calculated cell
number of HUVECs, which migrated through the pores of the cell
culture insert to the hydrogel substrate with and without SDF-1.
On both hydrogel types, but without SDF-1 only approximately
40 000 migrated HUVECs could be detected after six days of
culture. In contrast, on both hydrogel types loaded with SDF-1
approximately 60 000 cells could be detected already after two
Fig. 5 Assessment of cell proliferation by alamarBlue assay of hOBs and
HUVECs with and without hydrogel-associated cytokines SDF1 and BMP2,
respectively, on the dextran (A) and pullulan–amylose (B) hydrogel systems
(with the gain settings on the plate reader set to automatic adjustment.).
Fig. 6 Cell migration assay to test the influence of SD-1-modification on
the dextran and pullulan–amylose hydrogels with HUVECs. (A) Experimental
setup; (B) migration of HUVECs to dextran hydrogels with and without SDF1;
(C) migration of HUVECs to pullulan–amylose hydrogels with and without
SDF1. Asterisks indicate significant differences (p o 0.05).
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days of culture. After 6 days of culture, this number further
increased to 120 000 cells on dextran gels and 100 000 cells on
pullulan–amylose gels (Fig. 6, significance p o 0.05 on day 6).
In summary, the results of the migration and proliferation assays
confirm the indication that SDF-1 retains its positive influence on
proliferation and its chemotactic effect on endothelial cells after
incorporation into the hydrogel matrix.
The results of the migration assays confirm the data obtained
from the alamarBlue proliferation assay above by showing migration
of HUVECs through the cell culture insert to the SDF-1-modified
hydrogels. This behavior demonstrates the chemotactic character-
istic of SDF-1 to endothelial cells even after incorporation into the
hydrogels. Naderi-Meshkin59 demonstrated the chemotactic effect
of SDF-1 on adipose tissue-derived stem cells (hASC) in injectable
hydrogels and Prokoph et al.60,61 on circulating endothelial
progenitor cells (EPC) in heparin-based hydrogels. The present
findings demonstrate for the first time that incorporated SDF-1
retains its chemotactic effect on human umbilical endothelial
cells in dextran–. and pullulan–amylose based hydrogels.
3.7 Gene expression
In order to demonstrate the influence of incorporated cytokines on
gene regulation in the two employed cell types, analysis of specific
marker expressions of the respective cell types was performed by
real-time PCR. In the case of hOBs, the expression of Runt-related
transcription factor 2 (Runx2, a transcription factor required for
osteoblast differentiation), alkaline phosphatase (ALP, an early
marker protein of osteoblast differentiation), osteopontin (OP, an
important factor for biomineralization and bone remodeling)
and osterix (SSP1, a transcription factor required for osteoblast
differentiation) was significantly enhanced by a factor of 10-38
on BMP-2-modified hydrogels compared to cytokine-free gels
(p o 0.05). In all four analyzed genes concerning osteoblast
markers, the expression was more enhanced (p o 0.05) on
dextran gels compared to pullulan–amylose gels (Fig. 7A).
The expression of the endothelial marker CD31, von-
Willebrand-factor (vWF), and the VEGF-receptor KDR was signifi-
cantly enhanced by a factor of 2-18 in HUVECs after SDF-1
modification on both gel types (p o 0.05, Fig. 7B). In the case of
CD31, the expression was significantly enhanced on dextran gels
compared to pullulan–amylose gels, whereas only non-significant
differences between the two gel types were found concerning the
vWF and KDR gene expression.
The PCR data again confirm the functional activity of
entrapped and subsequently released growth factors and support
the proliferation and migration assay results (Fig. 5 and 6).
In the case of osteoblast markers, the enhancement is more
pronounced on dextran gels compared to amylose/pullulan gels,
which is in accordance with the former results. Summarizing the
enhancement of the expression of markers, especially ALP, Runx2
and SP7, and SP7 with an extremely high fold change of up to 30
indicated an immense is extremely high, indicating an immense
effect of BMP2 on osteoblast viability and differentiation. Chen
et al.62,63 and Dhivya et al.64 demonstrated an enhanced osteoblast
marker expression on thermo-responsive hydrogels and hyaluronic
acid-g-chitosan-g-poly(N-isopropylacrylamide) (HA-CPN) with fetal
osteoblasts after a long culture period (3–4 weeks) and nanohy-
droxyapatite–chitosan hydrogels with mouse mesenchymal stem
cells, respectively. They reported an up to 14-fold enhanced
expression of these markers; however, they employed hydrogels
without growth factors. Rath et al.65 implanted hyaluronan
hydrogels with BMP-2 or primary osteoblasts, but the although
gene expression of osteoblastic markers was enhanced, no
significant bone formation was observed. Kim et al.66 analyzed
hyaluronic acid-based hydrogels loaded with BMP-2 and
observed an enhanced marker expression (up to 30 fold)
comparable to our new results. In our study, the enhancement
of osteoblast marker expression was detected after BMP-2 loading
on all tested hydrogels. Our results as well as the results
described in the literature indicate that different hydrogels
enhance marker expression in osteoblasts and this enhancement
Fig. 7 Gene expression of osteoblast specific markers on hydrogels
loaded with BMP-2 (A) and endothelial markers on hydrogels loaded with
SDF-1 (B). Significant differences in the expression levels for a given marker
on the different gel types are indicated by the same letters.
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can be heightened by the addition of BMP-2. However, these
effects have to be further analyzed, examined and confirmed in
in vivo experiments.
To our knowledge, up to now no results exist for gene expression
analyses concerning HUVECs on hydrogels with or without SDF-1.
In our setup, the endothelial marker CD31 is more enhanced on
the dextran gel, whereas the other two markers, vWF and KDR,
appear marginally better on pullulan–amylose hydrogels. The
enhancement of CD31 gene expression is more pronounced than
the two other markers. As SDF-1 is an important contributor to
neovascularization67 and CD31 is highly expressed on cells
contributing to angiogenesis (reviewed in ref. 68), these results
match well. As the results obtained from the viability assay as
well as from the migration assays demonstrate better results for
dextran gels compared to pullulan/amylose gels it is a logical
consequence that CD31 expression is more enhanced on dextran
gels than on pullulan/amylose gels. With regard to vWF and
KDR, their expression is marginally better on pullulan/amylose
gels compared to dextran gels, yet these differences are not
statistically significant. Their overall expression enhancement
is much lower compared to CD31. This can be explained as these
markers are typically expressed on endothelial cells but their
expression is not as much correlated to angiogenesis as CD31.
vWF, for instance, plays an important role in hemostasis rather
than angiogenesis (reviewed by Yee et al., 201569).
We could clearly show that SDF-1 incorporated into polysacchar-
ide hydrogels enhances proliferation, migration and endothelial
marker expression, indicating the positive effect of SDF-1 on
endothelial cells even when loaded into polysaccharide hydrogels.
We believe that these results will be of great interest and
importance for applications where polysaccharide hydrogel
systems are used as cell and/or drug carriers in bone tissue
engineering.
4. Conclusions
In the present study, we have generated a range of different
polysaccharide-based hydrogel composites, which possess all
requirements demanded for a biomaterial. Dextran-based gels
demonstrated the best cellular growth, differentiation and pro-
liferation, whereas pullulan–amylose gels seem to have better
mechanical properties, thus proposing different application
areas for these two gel types. Dextran-based hydrogel composites
might be more suitable for cellular-based tissue engineering,
whereas pullulan–amylose hydrogel composites seem to be more
promising as carrier systems, especially concerning endothelial
enhancement by addition of SDF-1. The hydrogel composite
materials developed in this study can further find applications
in the modification of the existing materials approved by regula-
tory agencies for use in the human body. For example, the in vivo
performance of titanium implants approved by the FDA (Food
and Drug Administration) may be improved. We project that the
results presented here and the platform developed in the present
study will further aid in the development of novel and improved
implants for bone repair applications.
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